The Inhibitory Effect of Platelet Aggregation Ability Assessed by the Platelet Aggregatory Threshold Index in a Patient with Recurrent Stent Thrombosis.

Shojiro Hirano, Takayuki Yabe, Ryota Noike, Hideo Amano, Takanori Ikeda

Open access · diamondAbstract readCase Reports

In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.3field-weighted citation impact, top 37% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shojiro HiranoDivision of Cardiovascular Medicine, Department of Internal Medicine, Toho University, Japan.

Takayuki YabeDepartment of Cardiovascular Medicine, Toho University Graduate School of Medicine, Japan.

Ryota NoikeDivision of Cardiovascular Medicine, Department of Internal Medicine, Toho University, Japan.

Hideo AmanoDepartment of Cardiovascular Medicine, Toho University Graduate School of Medicine, Japan.

Takanori IkedaDepartment of Cardiovascular Medicine, Toho University Graduate School of Medicine, Japan.

Toho University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An 86-year-old man successfully underwent percutaneous coronary intervention (PCI), in which a drug-coated stent (DCS) was placed in the left anterior descending coronary artery. However, stent thrombosis occurred twice after eight and two months. After the second admission, the patient was tested for platelet aggregation activity using the platelet aggregation threshold index (PATI), and insufficient inhibition of platelet aggregation was observed. The patient's PATI improved to a satisfactory level using oral anticoagulants. At the six-month follow-up, clinical events were observed. Measuring the platelet aggregation ability can help clinicians understand the pathology of patients and determine treatment choices.

Indexed as

Drug-Eluting StentsPercutaneous Coronary InterventionPlatelet AggregationRecurrenceAged, 80 and overAnticoagulantsCoronary ThrombosisHumansMalePlatelet Aggregation InhibitorsPlatelet Function TestsStentsThrombosisAnticoagulantsPlatelet Aggregation Inhibitorsangina pectorisanti-platelet therapycardiovascular diseaseplatelet aggregationstent thrombosis

Identifiers

PMID37813611

DOI10.2169/internalmedicine.2545-23

PMCPMC11157312

OpenAlexW4387359743

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.